top of page
News
Chat
Analysis
Education
About
Pricing
BPIQ API
BPIQ Blog
Jun 23, 2018
1 min read
GBT's Part A Phase 3 Sickle Cell Data - Any Day Now
Looking forward to Global Blood Therapeutics report out of Part A from their Phase 3 Hope study of their drug voxelotor (formerly GBT440)...
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
